Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short‐term treatment effectiveness

Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short‐term treatment effectiveness

Bibliographic Details
Main Authors:	Dong Liu, Jingyun Li, Yunbo Gao, Feifei Cao, Wei Xiong, Chengshuo Wang, Yuan Zhang, Luo Zhang
Format:	Article
Language:	English
Published:	Wiley 2023-02-01
Series:	Clinical and Translational Allergy
Online Access:	https://doi.org/10.1002/clt2.12223

Similar Items

Alternatives to Subcutaneous Immunotherapy for Allergic Rhinitis
by: Tetsuya Terada, et al.
Published: (2022-02-01)

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
by: Lei Ren, et al.
Published: (2023-03-01)

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis
by: Anang Endaryanto, et al.
Published: (2022-05-01)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy
by: Peiyan Zheng, et al.
Published: (2021-09-01)

Association between the Interaction of Key Genes Involved in Effector T-Cell Pathways and Susceptibility to Develop allergic Rhinitis: A Population-Based Case-Control Association Study.
by: Yuan Zhang, et al.
Published: (2015-01-01)

Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
by: Edyta Jura-Szołtys, et al.
Published: (2022-07-01)

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis
by: Jingyu Huang, MS, et al.
Published: (2023-08-01)

Prediction of clinical efficacy of subcutaneous immunotherapy for Artemisia sieversiana pollen allergic rhinitis by serum metabolomics
by: Rui-Li Yu, et al.
Published: (2022-12-01)

Cluster subcutaneous allergen specific immunotherapy for the treatment of allergic rhinitis: a systematic review and meta-analysis.
by: Shaoyan Feng, et al.
Published: (2014-01-01)

House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up
by: Elena Rodriguez‐Plata, et al.
Published: (2023-10-01)

Skin prick tests and subcutaneous immunotherapy with standardized allergens in children with moderate-to-severe allergic rhinitis
by: Nihar Ranjan Mishra, et al.
Published: (2021-01-01)

The Safety of Immunotherapy in Patients with Allergic Asthma and Allergic Rhinitis
by: G. Ilonidis, et al.
Published: (2005-01-01)

Allergen-specific immunotherapy in allergic rhinitis
by: V. V. Klimov, et al.
Published: (2022-07-01)

Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis
by: Zao Ji, et al.
Published: (2023-03-01)

Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis
by: Jiumei Yang, et al.
Published: (2023-12-01)

Exosomes Derived hsa-miR-4669 as a Novel Biomarker for Early Predicting the Response of Subcutaneous Immunotherapy in Pediatric Allergic Rhinitis
by: Jiang S, et al.
Published: (2022-09-01)

Mechanism and clinical evidence of immunotherapy in allergic rhinitis
by: Marco De Carli, et al.
Published: (2023-08-01)

Applications and mechanisms of immunotherapy in allergic rhinitis and asthma
by: Jasper H. Kappen, et al.
Published: (2017-01-01)

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
by: Yinhui Zeng, MD, et al.
Published: (2023-07-01)

Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling
by: Shaobing Xie, et al.
Published: (2022-01-01)

Indonesia-Based Study of the Clinical and Cost-Saving Benefits of Subcutaneous Allergen Immunotherapy for Children with Allergic Rhinitis in Private Practice
by: Anang Endaryanto, et al.
Published: (2021-07-01)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
by: Sophia Tsabouri, et al.
Published: (2017-04-01)

Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
by: Kawita Atipas, et al.
Published: (2022-08-01)

Research progress on non-specific immunotherapy for allergic rhinitis
by: Han Dongyuan, Xu Bohuai, Yu Lujie, Qiu Qiyang, He Yong
Published: (2022-11-01)

Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study
by: Masaaki Hamada, et al.
Published: (2023-10-01)

Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis
by: Andrzej Bożek, et al.
Published: (2023-07-01)

A Real-World Effectiveness of Subcutaneous Immunotherapy on the Cost of Medication, Allergic Rhinitis, and Asthma Exacerbations, as well as Upper Respiratory Tract Infection in Subjects with Allergic Rhinitis with or without Asthma: A Retrospective Pilot Study
by: Chaicharn Pothirat, et al.
Published: (2021-11-01)

Clinical and immunological effect of subcutaneous immunotherapy in allergic asthma
by: Eman O. Arram, et al.
Published: (2017-04-01)

Extracts from The Cochrane Library: Sublingual immunotherapy for allergic rhinitis.
by: Burton, M, et al.
Published: (2011)

Antigen-Specific Immunotherapy against Allergic Rhinitis: The State of the Art
by: Takashi Fujimura, et al.
Published: (2010-01-01)

A single center retrospective study of systemic reactions’ distribution and risk factors to subcutaneous immunotherapy with dust mite extract in patients with allergic rhinitis and/ or asthma
by: Xude Zhang, et al.
Published: (2023-01-01)

Allergic rhinitis
by: K. S. Pavlova
Published: (2013-12-01)

Allergic rhinitis
by: S. V. Ryazantsev, et al.
Published: (2018-11-01)

Salivary IgG4 Levels Contribute to Assessing the Efficacy of <i>Dermatophagoides pteronyssinus</i> Subcutaneous Immunotherapy in Children with Asthma or Allergic Rhinitis
by: Jinling Liu, et al.
Published: (2023-02-01)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
by: Natalija Novak, et al.
Published: (2022-10-01)

Molecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis
by: Marina Izmailovich, et al.
Published: (2023-01-01)

Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
by: Wang Jiarong, et al.
Published: (2021-05-01)

Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis
by: Kai Fan, et al.
Published: (2023-07-01)

Knowledge, attitudes, and practice towards allergic rhinitis in patients with allergic rhinitis: a cross-sectional study
by: Wenzhe Gu, et al.
Published: (2023-08-01)

Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis
by: Sijie Jiang, et al.
Published: (2023-01-01)